These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12703209)

  • 1. The graft-versus-tumor effect and escape of malignancy from immune regulation.
    Malkovska V; Barrett J
    Cancer Chemother Biol Response Modif; 2002; 20():273-89. PubMed ID: 12703209
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
    Kline J; Subbiah S; Lazarus HM; van Besien K
    Bone Marrow Transplant; 2008 Mar; 41(6):505-13. PubMed ID: 18026144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of immune escape of cancer and its regulation.
    Morita R; Hirohashi Y; Torigoe T
    Rinsho Ketsueki; 2009 May; 50(5):375-80. PubMed ID: 19483397
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous tumor rejection in humans: trimming the myths.
    Wang E; Panelli M; Marincola FM
    Immunol Invest; 2006; 35(3-4):437-58. PubMed ID: 16916761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escape from immune- and nonimmune-mediated tumor surveillance.
    Malmberg KJ; Ljunggren HG
    Semin Cancer Biol; 2006 Feb; 16(1):16-31. PubMed ID: 16140546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic and tumor immunology: a review.
    Melvold RW; Sticca RP
    Surg Oncol Clin N Am; 2007 Oct; 16(4):711-35, vii. PubMed ID: 18022541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Ruggero ceppellini" advanced school of immunology.
    Di Giacomo A
    Eur J Immunol; 2009 Jul; 39(7):1692-3. PubMed ID: 19582735
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L; Carbone DP
    Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pattern recognition receptor-mediated immune tolerance is involved in tumor metastasis].
    Hu ZW; Yang HZ
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):5-10. PubMed ID: 21417007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease.
    Sackstein R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):2-8. PubMed ID: 16399577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I down-regulation: tumour escape from immune surveillance? (review).
    Bubeník J
    Int J Oncol; 2004 Aug; 25(2):487-91. PubMed ID: 15254748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the self/non-self-survey in the defense against cancer: potential for chemoprevention?
    Sharma RA; Browning MJ
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):5-22. PubMed ID: 15978831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
    Mapara MY; Sykes M
    J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKG2D ligands in tumor immunity.
    Nausch N; Cerwenka A
    Oncogene; 2008 Oct; 27(45):5944-58. PubMed ID: 18836475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated dormancy: an equilibrium with cancer.
    Teng MW; Swann JB; Koebel CM; Schreiber RD; Smyth MJ
    J Leukoc Biol; 2008 Oct; 84(4):988-93. PubMed ID: 18515327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
    Morecki S; Yacovlev E; Gelfand Y; Vilensky A; Slavin S
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cell role in tumor-related inflammation.
    Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
    Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-released microvesicles as vehicles of immunosuppression.
    Valenti R; Huber V; Iero M; Filipazzi P; Parmiani G; Rivoltini L
    Cancer Res; 2007 Apr; 67(7):2912-5. PubMed ID: 17409393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between immunological defence and the development of tumours].
    Leone G
    Arch Sci Med (Torino); 1973; 130(4):273-82. PubMed ID: 17343168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.